Showing results (1-10 of 4,133) with videos related to
Sort By:
Pageof 414
Oncogene|November 21, 1998
Mdm2 association with p53 targets its ubiquitinationS Y Fuchs, V Adler, T Buschmann, et al.Cancer Research|March 8, 2000
p53 phosphorylation and association with murine double minute 2, c-Jun NH2-terminal kinase, p14ARF, and p300/CBP during the cell cycle and after exposure to ultraviolet irradiationT Buschmann, V Adler, E Matusevich, et al.Genes & Development|September 10, 1998
JNK targets p53 ubiquitination and degradation in nonstressed cellsS Y Fuchs, V Adler, T Buschmann, et al.Journal of Molecular Biology|February 5, 2000
Analysis of JNK, Mdm2 and p14(ARF) contribution to the regulation of mutant p53 stabilityT Buschmann, T Minamoto, N Wagle, et al.Proceedings of the National Academy of Sciences of the United States of America|September 2, 1998
MEKK1/JNK signaling stabilizes and activates p53S Y Fuchs, V Adler, M R Pincus, et al.Cell|July 13, 2000
SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53T Buschmann, S Y Fuchs, C G Lee, et al.The Journal of Biological Chemistry|March 30, 2001
Stabilization and activation of p53 by the coactivator protein TAFII31T Buschmann, Y Lin, N Aithmitti, et al.Molecular and Cellular Biology|April 17, 1999
Ubiquitination and degradation of ATF2 are dimerization dependentS Y Fuchs, Z RonaiCancer Letters|April 19, 1996
Elevated binding to URE/PEBP2 during the late stages of NNK and benzo[a]pyrene-induced carcinogenesis in A/J miceS Y Fuchs, Z RonaiOncogene|March 4, 1998
ATF2 confers radiation resistance to human melanoma cellsZ Ronai, Y M Yang, S Y Fuchs, et al.Pageof 414